文献速递医学教育与科研方法临床试验与 GCP

更清晰地报告减药试验:CONSORT声明的扩展解读

Describing deprescribing trials better: an elaboration of the CONSORT statement.
PubMed 文献 · J Clin Epidemiol · 2020-07-22

该研究基于减药试验的系统综述,识别设计与报告差异,结合CONSORT和TIDieR清单找出遗漏或描述不足的条目,经14位国际专家单轮德尔菲和面对面会议达成共识,最终确定7个需特别考虑的CONSORT条目,为减药试验报告提供扩展解读。

要点

  • 减药试验报告应关注7个CONSORT条目中的特定方面。
  • 特定方面包括是否使用安慰剂、如何告知参与者等设计细节。
  • 该扩展解读可支持研究者做出有依据的设计选择。

核心结论

  • 本文提出了针对减药试验报告的CONSORT声明扩展解读,并可能支持研究者做出有依据的设计选择。

研究设计与样本

  • 基于减药试验的系统综述,结合CONSORT和TIDieR清单识别遗漏或描述不足的条目,经单轮德尔菲和14位国际专家面对面会议达成共识。

主要发现

  • 识别出7个CONSORT条目(涉及试验设计、参与者、干预、结局、流程图和伤害),减药试验研究者应考虑其中特定方面,如是否使用安慰剂或如何告知参与者。

关键数值与推荐

  • 7个CONSORT条目需在减药试验中特别考虑:试验设计、参与者、干预、结局、流程图和伤害。

临床怎么用

  • 研究者报告减药试验时可参照此扩展解读,并在设计时考虑是否使用安慰剂、如何告知参与者等特定方面。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to identify key features to be addressed in the reporting of deprescribing trials and to elaborate and explain CONSORT items in this regard. STUDY DESIGN AND SETTING: As a first step in a multistage process and based on a systematic review of deprescribing trials, we elaborated variation in design, intervention, and reporting of the included trials of the review. We identified items that were missed or insufficiently described, using the CONSORT and TIDieR checklists. The resulting list of items, which we considered relevant to be reported in deprescribing trials, were discussed in a single-round Delphi exercise and subsequently in a full-day face-to-face meeting with an international panel of 14 experts. We agreed on CONSORT items for further elaboration with regard to design and reporting of deprescribing trials. RESULTS: We identified seven CONSORT items on trial design, participants, intervention, outcomes, flowchart, and harms, where the investigators of deprescribing trials should take into consideration specific aspects, such as whether or not to use placebo or how to inform participants. CONCLUSION: This article presents an elaboration to the CONSORT statement for the reporting of deprescribing trials. It may also support investigators in motivated design choices.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Blom JW, Muth C, Glasziou P, et al. Describing deprescribing trials better: an elaboration of the CONSORT statement. J Clin Epidemiol. 2020. PMID: 32707072. doi:10.1016/j.jclinepi.2020.07.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。